Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Oct 7, 2011

Premium

Gail Page has stepped down as chairman of the board at Vermillion. Page will still remain CEO. In her place, the company elected James Burns as chairman.

Burns has been a director of the board since 2005, and is the president and CEO of AssureRx. Previously he was president and CEO of EntreMed.


Waters has recognized the University of Minnesota's Mass Spectrometry Laboratory as a Waters Center of Innovation, citing in particular the work of the facility's head Joseph Dalluge.

Dalluge is the thirteenth researcher recognized by the program. His research focuses on diagnostic marker development for cystic fibrosis and other diseases, using LC-MS instruments including Waters' Aqcuity UPLC/TQD and Synapt G2 for metabolite profiling, biomarker discovery, and chemical characterization of biological systems.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.